Combination of doses, better than monotherapy for pulmonary hypertension

Published Date: 08 Mar 2023

People with hypertension (high blood pressure in the arteries that supply the lungs, also known as PAH) have up to a two-fold reduction in pulmonary vascular resistance (PVR) when taking PAH.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Molecular profiling of renal medullary carcinoma identifies TROP2 as a promising therapeutic target

2.

High numbers of rural patients cross state lines for cancer care

3.

Adult survivors of childhood cancer are at high risk for cognitive impairment, according to JAMA.

4.

CAR Natural Killer Cell Therapy Shows Promise in B-Cell Lymphomas

5.

Novel biomarkers may improve diagnosis of gallbladder cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot